Clinical Trial Update: Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the effect of BIA 9-1067 on cardiac repolarization in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED